Webinar Series

Pitfalls and problems of miRNA expression analysis

About OTS

………………………….

The Oligo Meeting

The highly regarded annual OTS meeting draws experts from all over the world for cross-disciplinary exchange spanning expertise in chemistry and delivery, to biology, immunology and clinical medicine. It is the intense scientific exchange between attendees during our annual meetings that sets the stage for groundbreaking new ideas.

Click here to take advantage of an array of benefits that support the society’s mission.

What is Oligo Therapeutics?

Therapeutic oligonucleotides include a wide spectrum of molecules with different chemistries and functional properties such as antisense, RNA interference, immunorecognition and aptamer binding.

Awards & Grants

clear

Board of Directors

clear

Scientific Advisory Council

clear

Mission & History

clear

Past OTS Annual Meetings

Photo Gallery

Official Journal of the Society

Nucleic Acid Therapeutics is the leading journal in its field focusing on cutting-edge basic research, therapeutic applications, and drug development using nucleic acids or related compounds to alter gene expression. The Journal examines many new approaches for using nucleic acids as therapeutic agents or in modifying nucleic acids for therapeutic purposes including: oligonucleotides, gene modification, aptamers, RNA nanoparticles, and ribozymes.

Become A Member

Membership is an opportunity to take advantage of an array of benefits that support the society’s mission to foster academia and industry-based research and development of oligonucleotide therapeutics, all at a reasonable rate!

The Oligonucleotide Therapeutics Society (OTS) offers the opportunity for both members and non-members to apply for various awards to support the accomplishments of students, postdocs and young investigators.

Carlo M. Croce is an Italian Medical Doctor and Oncologist noted for research into the genetic mechanisms of cancer. Croce is one of the most highly recognized and awarded Italian researchers in the world, and is currently involved in the study of microRNAs and their role in oncology.